Stock Region Penny Picks
Stock Region Penny Picks
Stock Region Penny Picks Newsletter - Wednesday, September 18th, 2024
Stock Region Penny Picks Newsletter - Wednesday, September 18th, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Readers should conduct their own research and consult with a financial advisor before making any investment decisions.
$VVOS - Vivos Therapeutics has received a groundbreaking FDA 510(k) clearance to treat moderate to severe pediatric sleep apnea and snoring. This regulatory milestone could potentially open up new market opportunities for Vivos Therapeutics in pediatric healthcare.
$APLT - Applied Therapeutics has provided a regulatory update on Govorestat, a promising treatment for Classic Galactosemia. This update is crucial for stakeholders monitoring the progression of this therapeutic candidate through regulatory pathways.
$NVVE - Nuvve Holding Corp. has undergone a 1:10 reverse stock split, effective from Monday. Investors should take note of this change as it impacts the number of shares outstanding and share price.
$VCNX - Vaccinex has announced the exercise of warrants, generating $6.2 million in gross proceeds. This influx of capital is expected to support the company's ongoing operations and strategic initiatives.
$BCDA - BioCardia has regained full compliance with Nasdaq listing requirements. This achievement ensures the continuity of its listing and provides confidence to investors regarding the company's adherence to regulatory standards.
$VTAK - Catheter Precision, Inc. is expanding the distribution of its LockeT technology to the Middle East, enhancing its global footprint and potentially increasing its market share in international markets.
$AILE - iLearningEngines and GenLab Venture Studio have announced a strategic alliance aimed at fast-tracking enterprise AI applications using generative AI across global enterprises. This collaboration is expected to accelerate innovation and adoption of AI solutions in various sectors.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Readers should conduct their own research and consult with a financial advisor before making any investment decisions.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net